Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Werewolf Therapeutics, Inc. (HOWL)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -360.2% | -479.4% | -771.7% | |
ROIC (including intangibles) | -418.1% | -282.6% | -706.2% | -377.2% |
ROE | -45.8% | -32.8% | -25.1% | -101.7% |
ROA | -35.0% | -27.9% | -23.2% | -45.8% |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 0.0 | | 0.0 |
Days payables outstanding | -30.8 | 7,149.1 | | 18.2 |
Cash conversion cycle | 30.8 | -7,149.1 | | -18.2 |
|